What Has Been The Evolution of the Cardiac Mapping Market in Recent Years?
The cardiac mapping market has seen considerable growth due to a variety of factors.
• The cardiac mapping market has experienced steady growth in recent years. It will increase from $2.3 billion in 2024 to $2.48 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.6%.
This growth can be attributed to the introduction of catheter ablation techniques, the development of 3D mapping systems, advancements in imaging technologies, and the rising prevalence of cardiac arrhythmias, along with growth in minimally invasive procedures.
What Is the Forecasted Market Size and Growth Rate for The Cardiac Mapping Market Size In The Coming Years?
The cardiac mapping market is expected to maintain its strong growth trajectory in upcoming years.
• The cardiac mapping market is expected to grow to $3.29 billion by 2029, with a CAGR of 7.3%.
Growth is attributed to the rising prevalence of cardiovascular diseases, an aging population, increased awareness and screening, improved healthcare infrastructure, and the rise in health issues. Trends include AI integration, real-time 3D mapping, improved catheter technologies, cloud-based data analysis, and enhanced electrophysiology software.
What Factors Are Driving Growth In The Cardiac Mapping Market?
The growing prevalence of heart ailments is expected to propel the growth of the cardiac mapping market. Heart ailments are caused by various conditions affecting the heart's function, leading to complications such as arrhythmias and heart attacks. These conditions are increasing due to unhealthy lifestyles and aging populations. Cardiac mapping helps in diagnosing and treating these ailments by identifying electrical abnormalities in the heart. The British Heart Foundation reported in January 2024 that over one million individuals in the UK suffer from heart failure, contributing to a significant demand for cardiac mapping technologies. Therefore, the increasing prevalence of heart diseases is boosting the cardiac mapping market.
What Are The Main Segments Of The Global Cardiac Mapping Market?
The cardiac mapping market covered in this report is segmented –
1) By Type: Contact Cardiac Mapping Systems, Non-Contact Cardiac Mapping Systems
2) By Indications: Atrial Fibrillation, Atrial Flutter, Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Other Indications
3) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End-Users
Subsegments:
1) By Contact Cardiac Mapping Systems: Electrode-Based Mapping Systems, Catheter-Based Mapping Systems, Integrated Mapping And Ablation Systems, 3D Mapping Systems
2) By Non-Contact Cardiac Mapping Systems: Non-Contact Voltage Mapping Systems, Electrocardiographic Mapping Systems, Optical Mapping Systems, Magnetic Field Mapping Systems
Pre-Book The Cardiac Mapping Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Cardiac Mapping Market?
Companies in the cardiac mapping market are advancing diagnostic accuracy by developing cardiac mapping platforms. These platforms help visualize and analyze electrical activity within the heart. In January 2022, Abbott Laboratories received FDA approval for its EnSite X EP system, a cardiac mapping platform designed to identify the origins of abnormal heart rhythms. The system creates detailed 3D heart maps using Abbott's proprietary technology to provide accurate diagnosis and treatment.
Who Are the Key Players In The Cardiac Mapping Market?
Major companies operating in the cardiac mapping market are:
• Johnson & Johnson
• Abbott Laboratories
• Medtronic plc
• Koninklijke Philips N.V.
• GE Healthcare Technologies
• Boston Scientific Corporation
• Epmap-System
• APN Health LLC
• BIOTRONIK SE & Co. KG
• Lepu Medical Technology Co. Ltd.
• MicroPort Scientific Corporation
• Biosense Webster Inc.
• BioSig Technologies Inc.
• CardioFocus Inc.
• Kardium Inc.
• Acutus Medical Inc.
• Navix Medical Ltd.
• EP Solutions SA
• CoreMap Inc.
• Catheter Precision Inc.
What Is The Most Dominant Region In The Cardiac Mapping Market?
North America was the largest region in the cardiac mapping market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac mapping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
